Citi raised the firm’s price target on Exact Sciences (EXAS) to $85 from $65 and keeps a Buy rating on the shares.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXAS:
- Cathie Wood Buys the Dip in Archer Aviation (ACHR) After Weak Q3 Results, Trims Stakes in Roku and TER Stocks
- Exact Sciences announces results from ALTUS study
- Exact Sciences Corp Faces Regulatory Risks Amid Potential Government Disruptions
- Exact Sciences Corp Reports Strong Q3 Earnings
- Midday Fly By: Palantir reports Q3 beat, Starbucks forms China JV